Abstract CT216: A phase 0 master protocol utilizing a novel intratumoral microdosing approach for simultaneously evaluating multiple drugs and drug combinations in patients with solid tumors
Year: 2022
Type: conference-abstract
Source: Cancer Research
Authors: Karthik Rajasekaran, Jason G. Newman, Robert G. Maki, Thomas J. Ow, Vikas Mehta, Kenneth R. Gundle, Daniel R. Clayburgh, Ryan J. Li, Mercedes Porosnicu, Cherie-Ann O. Nathan, Alice Tang, Beryl A. Hatton, Kimberly H. Sottero, Gloria Kung, Marc O. Grenley, Kirsten Anderson, Richard A. Klinghoffer
Institutions: University of Pennsylvania, Albert Einstein College of Medicine, Montefiore Medical Center, Oregon Health & Science University, Wake Forest University Health Sciences, Wake Forest University, Louisiana State University Health Sciences Center Shreveport, University of Cincinnati, Presage Biosciences (United States)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4282965855